Symptomatic vulvovaginal candidiasis and antifungal resistance in HIV-1 positive women at Mbarara city health centre IV
Abstract Vulvovaginal candidiasis (VVC) represents a universal health hazard that contributes to significant morbidity in HIV-positive women. Antifungal resistance is a worldwide increasing health problem that reduces treatment options while increasing treatment costs. The purpose of this study was...
Saved in:
| Main Authors: | Nusifah Mbatudde, Pauline Petra Nalumaga, Joel Bazira, Taseera Kabanda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-09215-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis
by: Vasiliki Kroustali, et al.
Published: (2025-03-01) -
In vitro antifungal activities of some mushroom extracts against yeast isolates among women with vulvovaginal candidiasis in a teaching hospital
by: Adewale Oke, et al.
Published: (2025-06-01) -
Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial
by: Maryam Ramazany Chaleshtori, et al.
Published: (2025-04-01) -
Estimation of Immunoglobulins and complements and Using Enzyme linked Immuno sorbant Assay in Identification of Vulvovaginal candidiasis
by: Baghdad Science Journal
Published: (2009-09-01) -
Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)
by: Oksana N. Volkova, et al.
Published: (2025-02-01)